FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203758519> ?p ?o ?g. }

• W3203758519 endingPage "805" @default.
• W3203758519 startingPage "799" @default.
• W3203758519 abstract "To identify anatomic endpoints altered by intravitreal ranibizumab in central retinal vein occlusion (CRVO) to determine any potential underlying disease modification that occurs with anti-vascular endothelial growth factor (anti-VEGF) therapy beyond best-corrected visual acuity and central optical coherence tomography outcomes.A post hoc analysis of a double-masked, multicenter, randomized clinical trial was performed. A total of 392 patients with macular edema after CRVO were randomized 1:1:1 to receive monthly intraocular injections of 0.3 or 0.5 mg of ranibizumab or sham injections. Central reading center-read data were reviewed to explore potential anatomic endpoints altered by therapy.At 6 months, there was a reduction in the ranibizumab groups compared with sham groups with respect to total area of retinal hemorrhage (median change from baseline in disc areas: - 1.17 [sham], - 2.37 [ranibizumab 0.3 mg], - 1.64 [ranibizumab 0.5 mg]), development of disc neovascularization (prevalence: 3% [sham], 0% [ranibizumab 0.3 mg], 0% [ranibizumab 0.5 mg]), and presence of papillary swelling (prevalence: 22.9% [sham], 8.0% [ranibizumab 0.3 mg], 8.3% [ranibizumab 0.5 mg], p < 0.01). There was no difference between groups in collateral vessel formation. Analysis of vitreous and preretinal hemorrhage could not be performed due to low frequency of events in both treated and sham groups.Ranibizumab for CRVO resulted in beneficial disease-modifying effects through a reduction in retinal hemorrhage, neovascularization, and papillary swelling. These findings may form the basis for future work in the development of a treatment response or severity scale for eyes with CRVO." @default.
• W3203758519 created "2021-10-11" @default.
• W3203758519 creator A5002283547 @default.
• W3203758519 creator A5017043678 @default.
• W3203758519 creator A5041378794 @default.
• W3203758519 creator A5044217019 @default.
• W3203758519 creator A5049198875 @default.
• W3203758519 creator A5051317487 @default.
• W3203758519 creator A5058468857 @default.
• W3203758519 creator A5058944747 @default.
• W3203758519 creator A5077249261 @default.
• W3203758519 date "2021-10-06" @default.
• W3203758519 modified "2023-09-27" @default.
• W3203758519 title "Disease-modifying effects of ranibizumab for central retinal vein occlusion" @default.
• W3203758519 cites W1967244076 @default.
• W3203758519 cites W1978704499 @default.
• W3203758519 cites W1983275936 @default.
• W3203758519 cites W1999957425 @default.
• W3203758519 cites W2034294591 @default.
• W3203758519 cites W2034477424 @default.
• W3203758519 cites W2035855497 @default.
• W3203758519 cites W2052204551 @default.
• W3203758519 cites W2057789225 @default.
• W3203758519 cites W2057880134 @default.
• W3203758519 cites W2058312539 @default.
• W3203758519 cites W2064362164 @default.
• W3203758519 cites W2083648307 @default.
• W3203758519 cites W2084575920 @default.
• W3203758519 cites W2087899702 @default.
• W3203758519 cites W2089494988 @default.
• W3203758519 cites W2102463203 @default.
• W3203758519 cites W2103827117 @default.
• W3203758519 cites W2107443927 @default.
• W3203758519 cites W2128701654 @default.
• W3203758519 cites W2137893922 @default.
• W3203758519 cites W2142651474 @default.
• W3203758519 cites W2144771657 @default.
• W3203758519 cites W2155651989 @default.
• W3203758519 cites W2166985747 @default.
• W3203758519 cites W2178156144 @default.
• W3203758519 cites W2594336900 @default.
• W3203758519 cites W2612836720 @default.
• W3203758519 cites W2616361514 @default.
• W3203758519 cites W2801073872 @default.
• W3203758519 cites W2894823502 @default.
• W3203758519 cites W2909261967 @default.
• W3203758519 doi "https://doi.org/10.1007/s00417-021-05224-x" @default.
• W3203758519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34613454" @default.
• W3203758519 hasPublicationYear "2021" @default.
• W3203758519 type Work @default.
• W3203758519 sameAs 3203758519 @default.
• W3203758519 citedByCount "1" @default.
• W3203758519 countsByYear W32037585192022 @default.
• W3203758519 crossrefType "journal-article" @default.
• W3203758519 hasAuthorship W3203758519A5002283547 @default.
• W3203758519 hasAuthorship W3203758519A5017043678 @default.
• W3203758519 hasAuthorship W3203758519A5041378794 @default.
• W3203758519 hasAuthorship W3203758519A5044217019 @default.
• W3203758519 hasAuthorship W3203758519A5049198875 @default.
• W3203758519 hasAuthorship W3203758519A5051317487 @default.
• W3203758519 hasAuthorship W3203758519A5058468857 @default.
• W3203758519 hasAuthorship W3203758519A5058944747 @default.
• W3203758519 hasAuthorship W3203758519A5077249261 @default.
• W3203758519 hasBestOaLocation W32037585191 @default.
• W3203758519 hasConcept C118487528 @default.
• W3203758519 hasConcept C141071460 @default.
• W3203758519 hasConcept C2776694085 @default.
• W3203758519 hasConcept C2777802072 @default.
• W3203758519 hasConcept C2778257484 @default.
• W3203758519 hasConcept C2778844676 @default.
• W3203758519 hasConcept C2780347916 @default.
• W3203758519 hasConcept C2780827179 @default.
• W3203758519 hasConcept C2781100027 @default.
• W3203758519 hasConcept C71924100 @default.
• W3203758519 hasConceptScore W3203758519C118487528 @default.
• W3203758519 hasConceptScore W3203758519C141071460 @default.
• W3203758519 hasConceptScore W3203758519C2776694085 @default.
• W3203758519 hasConceptScore W3203758519C2777802072 @default.
• W3203758519 hasConceptScore W3203758519C2778257484 @default.
• W3203758519 hasConceptScore W3203758519C2778844676 @default.
• W3203758519 hasConceptScore W3203758519C2780347916 @default.
• W3203758519 hasConceptScore W3203758519C2780827179 @default.
• W3203758519 hasConceptScore W3203758519C2781100027 @default.
• W3203758519 hasConceptScore W3203758519C71924100 @default.
• W3203758519 hasFunder F4320306811 @default.
• W3203758519 hasFunder F4320332193 @default.
• W3203758519 hasIssue "3" @default.
• W3203758519 hasLocation W32037585191 @default.
• W3203758519 hasLocation W32037585192 @default.
• W3203758519 hasLocation W32037585193 @default.
• W3203758519 hasOpenAccess W3203758519 @default.
• W3203758519 hasPrimaryLocation W32037585191 @default.
• W3203758519 hasRelatedWork W1668980245 @default.
• W3203758519 hasRelatedWork W1997095687 @default.
• W3203758519 hasRelatedWork W2321207693 @default.
• W3203758519 hasRelatedWork W2413823267 @default.
• W3203758519 hasRelatedWork W2513291393 @default.
• W3203758519 hasRelatedWork W2521155275 @default.

• next